EUVIMEDOpdag EUVIMED
MetaanalyseSystematische Übersicht

Meta‐Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes

Sahand Karimzadhagh iD, Elahe Abbaspour, Maryam Shahriarinamin, Pourya Shamsi, Selvana Poursadrolah, Mehrdad Khorasani, Mahzad Daghighi, Arash Malek, Jouan Taheri Talesh, Govind K Makharia iD, Mohammad Rostami-Nejad iD

Alimentary Pharmacology & Therapeutics · 2025-01 · 61 (1) · 8-31

DOI: 10.1111/apt.18373 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2024-11-04. Written by Sahand Karimzadhagh and 10 co-authors. Institution: Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University o…. Major MEDLINE topics: Celiac Disease, Diabetes Mellitus, Type 1, Global Health. Cited 20 times so far (Crossref); 157 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Coeliac disease (CD) is common in patients with type 1 diabetes (T1D), but prevalence varies globally due to differing screening protocols. There have been substantial changes in screening guidelines over the past two decades.

Aim

To evaluate CD prevalence in patients with T1D, focusing on screening studies using antitissue transglutaminase (anti‐tTG) antibody.

Methods

We searched PubMed, Web of Science, Embase and Scopus for studies published up to 11 December 2023 using keywords related to CD and diabetes. We used random‐effects models for overall prevalence and all subgroups, with heterogeneity assessed using Cochran's Q test and the I 2 statistic performed in STATA 18.

Results

We included 106 articles involving 65,102 T1D patients across 40 countries. The pooled CD seroprevalence and confirmed CD prevalence were 9% (95% confidence interval, CI, 8%–10%) and 6% (95% CI 5%–7%), respectively. The prevalence was higher in females and children. Denmark, Saudi Arabia and Libya exhibited the highest prevalence (11%), followed by India and Egypt (10%). Belgium, France, Germany, South Africa and the United States had the lowest prevalence (2%). High‐income countries showed significantly a lower CD prevalence than middle‐income countries ( p = 0.03). Meta‐regression based on the Human Development Index (HDI) indicated that countries with higher HDI have lower seroprevalence and confirmed CD prevalence.

Conclusion

Approximately 1 in 16 patients globally and 1 in 12 patients in Asia and the Middle East with T1D has CD. We suggest that all patients with T1D should be screened for CD.

Subjects

MeSH terms (MEDLINE)

Celiac DiseaseDiabetes Mellitus, Type 1Global HealthHumansPrevalenceTransglutaminasesFemaleMaleSeroepidemiologic StudiesChildMass Screening

Author keywords

celiac diseasecoeliac diseasediabetes mellitusepidemiologymeta‐analysisprevalencetype 1 diabetes

Substances

Transglutaminases

Authors and institutions

  • Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.

ORCID profiles: Sahand Karimzadhagh, Govind K Makharia, Mohammad Rostami-Nejad

Cite

APA

Karimzadhagh, S., Abbaspour, E., Shahriarinamin, M., Shamsi, P., Poursadrolah, S., Khorasani, M., Daghighi, M., Malek, A., Talesh, J. T., Makharia, G. K., & Rostami-Nejad, M. (2025). Meta‐Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes. Alimentary Pharmacology & Therapeutics, 61(1), 8-31. https://doi.org/10.1111/apt.18373

Vancouver

Karimzadhagh S, Abbaspour E, Shahriarinamin M, Shamsi P, Poursadrolah S, Khorasani M, et al. Meta‐Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes. Alimentary Pharmacology & Therapeutics. 2025;61(1):8-31. doi:10.1111/apt.18373

BibTeX
@article{Karimzadhagh2025,
  author = {Karimzadhagh, Sahand and Abbaspour, Elahe and Shahriarinamin, Maryam and Shamsi, Pourya and Poursadrolah, Selvana and Khorasani, Mehrdad and Daghighi, Mahzad and Malek, Arash and Talesh, Jouan Taheri and Makharia, Govind K and Rostami-Nejad, Mohammad},
  title = {Meta‐Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {1},
  pages = {8--31},
  doi = {10.1111/apt.18373}
}
Start for free →